Impact of Stent Diameter on Vascular Response After Self-expanding Paclitaxel-eluting Stent Implantation in the Superficial Femoral Artery: An Optical Frequency Domain Imaging Study

Impact of Stent Diameter on Vascular Response After Self-expanding Paclitaxel-eluting Stent Implantation in the Superficial Femoral Artery: An Optical Frequency Domain Imaging Study - Optimal Diameter of Self-expanding Paclitaxel-eluting Stent in the Superficial Femoral Artery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015485

Enrollment

Registered

2014-12-01

Start date

2014-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Artery Disease

Interventions

paclitaxel-eluting stent implantation with the diameter of 6mm paclitaxel-eluting stent implantation with the diameter of 8mm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: PAD patients with isolated SFA lesion (length less than 150mm)

Exclusion criteria

Exclusion criteria: Patients with in-flow or out-flow disease Restenotic lesions

Design outcomes

Primary

Measure	Time frame
Lumen volume 6 months after self-expanding paclitaxel-eluting stent implantation	—

Secondary

Measure	Time frame
Neointimal volume 6 months after self-expanding paclitaxel-eluting stent implantation	—

Countries

Japan

Contacts

Public ContactKojiro Miki

Hyogo College of Medicine Cardiovascular Division

hpxkg043@ybb.ne.jp0798456553

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026